FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Amerisource Health Services HydrALAZINE Hydrochloride Tablets Recall

HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Onl…

Amerisource Health Services LLC · Columbus, OH

Risk level
Class III
Reported by FDA
Oct 11, 2023
Recall ID
D-0039-2024
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled HydrALAZINE Hydrochloride Tablets starting Sep 1, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0039-2024 on Oct 11, 2023. Reason: Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.

Product description

HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 68084-447-01; Individual Dose NDC: 68084-447-11

Lot numbers, UPCs & expiration codes

Lot#: 1007002, Exp 12/31/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0039-2024
Classification
Class III
Status
Terminated
Recall initiated
Sep 1, 2023
FDA report date
Oct 11, 2023
Quantity
3,344 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0039-2024, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
93089
Address
2550 John Glenn Ave Ste A
Code information
Lot#: 1007002, Exp 12/31/2023
Postal code
43217-1188
Report date
Oct 11, 2023
Product type
Drugs
Recall number
D-0039-2024
Classification
Class III
Recalling firm
Amerisource Health Services LLC
Product quantity
3,344 cartons
Termination date
Jul 16, 2024
Reason for recall
Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC#: 68084-447-01; Individual Dose NDC: 68084-447-11
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 1, 2023
Initial firm notification
Letter
Center classification date
Oct 5, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0039-2024, published Oct 11, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls